Science Park Company News
HKSTP Welcomes Rohto Advanced Research Hong Kong Limited to Science Park’s Biotechnology Ecosystem
Research arm of renowned Japanese pharmaceutical to focus on regenerative medicine and promote clinical applications in Hong Kong and China
06 Sep 2019

Kunio Yamada, Chairman and CEO, Rohto Pharmaceutical Co., Ltd. (left) and Albert Wong, CEO of Hong Kong Science and Technology Parks Corporation (right) officiated at the opening of Rohto Advanced Research Hong Kong Limited who joins Hong Kong Science Park to promote the R&D on regenerative medicine, cell culture technologies in Hong Kong.

Kunio Yamada, Chairman and CEO, Rohto Pharmaceutical Co., Ltd. (left) and Albert Wong, CEO of Hong Kong Science and Technology Parks Corporation (right) officiated at the opening of Rohto Advanced Research Hong Kong Limited who joins Hong Kong Science Park to promote the R&D on regenerative medicine, cell culture technologies in Hong Kong.

 

Hong Kong, 6 September 2019 – Hong Kong Science and Technology Parks Corporation (HKSTP) announced the latest Science Park addition to its biomedical technology ecosystem – Rohto Advanced Research Hong Kong Limited (RARHK), a subsidiary of Rohto Pharmaceutical Co., Ltd in Japan.

Rohto Pharmaceutical Co., Ltd is the Japanese manufacturer and marketer of pharmaceutical products, cosmetics and functional foods. Since the launch of gastrointestinal medicine Ikatsu in 1899, the company has continuously developed high value-added non-prescription medicine and health and beauty products and supplements.

Currently, Rohto Pharmaceutical Co., Ltd is is conducting a Phase I/II study of allogenic adipose-derived mesenchymal stromal cells against liver cirrhosis in Japan, and has developed an automated cell culture and storage system which allows large scale manufacturing at low cost.

Leveraging on the infrastructure and ecosystem at Hong Kong Science Park, RARHK will conduct basic research on mesenchymal stromal cells and other possible areas for the upcoming new era of cell therapies.

 

-End-

 

About Hong Kong Science and Technology Parks Corporation

Comprising Science Park, InnoCentre and Industrial Estates, Hong Kong Science & Technology Parks Corporation (HKSTP) is a statutory body dedicated to building a vibrant innovation and technology ecosystem to connect stakeholders, nurture technology talents, facilitate collaboration, and catalyse innovations to deliver social and economic benefits to Hong Kong and the region.

Established in May 2001, HKSTP has been driving the development of Hong Kong into a regional hub for innovation and growth in several focused clusters including Electronics, Information & Communications Technology, Green Technology, Biomedical Technology, Materials and Precision Engineering. We enable science and technology companies to nurture ideas, innovate and grow, supported by our R&D facilities, infrastructure, and market-led laboratories and technical centres with professional support services. We also offer value added services and comprehensive incubation programmes for technology start-ups to accelerate their growth.

Technology businesses benefit from our specialised services and infrastructure at Science Park for applied research and product development; enterprises can find creative design support at InnoCentre; while skill-intensive businesses are served by our three industrial estates at Tai Po, Tseung Kwan O and Yuen Long. More information about HKSTP is available at www.hkstp.org.

 

Media Contacts:

Hong Kong Science and Technology Parks Corporation

Julia Cheung

Tel: +852 2629 6891

Email: julia.cheung@hkstp.org

Ogilvy Public Relations

Matthew Liu

Tel: +852 2884 8474

Email: matthew.liu@ogilvy.com

 

arrow up arrow down arrow left arrow right icon close icon text icon help HKSTP Logo